#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4131389	F	Antidiabetic activity in Zucker rat chronic ob/ob model assessed as fasting blood glucose level at 3 mg/kg, po qd measured on day 14 (Rvb = 337.5 +/- 17.9 mg/dl)	Rattus norvegicus	1	ALA4130359	organism-based format	Scientific Literature
2.	ALA4131392	B	Antagonist activity at His6-tagged ERRalpha LBD (unknown origin) assessed as inhibition of GST-tagged SRC-2 co-activator peptide recruitment after 18 hrs by TR-FRET assay	Homo sapiens	31	ALA4130359	single protein format	Scientific Literature
3.	ALA4131393	F	Decrease in fed plasma insulin level in Zucker rat sub-chronic fa/fa prediabetic model assessed as change in plasma insulin level at 10 mg/kg, po qd for 4 days measured on day 5 relative to control	Rattus norvegicus	31	ALA4130359	organism-based format	Scientific Literature
4.	ALA4131394	F	Decrease in fed plasma triglyceride level in Zucker rat sub-chronic fa/fa prediabetic model assessed as change in plasma triglyceride level at 10 mg/kg, po qd for 4 days measured on day 5 relative to control	Rattus norvegicus	31	ALA4130359	organism-based format	Scientific Literature
5.	ALA4131398	F	Decrease in fed plasma glucose level in Zucker rat sub-chronic fa/fa prediabetic model at 10 mg/kg, po qd for 4 days measured on day 5 relative to control	Rattus norvegicus	3	ALA4130359	organism-based format	Scientific Literature
6.	ALA4131401	F	Antidiabetic activity in Zucker rat sub-chronic fa/fa prediabetic model assessed as decrease in plasma glucose AUC (0 to 120 mins) at 10 mg/kg, po qd during 10 days study by OGTT relative to control	Rattus norvegicus	2	ALA4130359	organism-based format	Scientific Literature
7.	ALA4131402	T	Toxicity in Zucker rat sub-chronic fa/fa prediabetic model assessed as increase in body weight at 10 mg/kg, po qd during 10 days study	Rattus norvegicus	2	ALA4130359	organism-based format	Scientific Literature
8.	ALA4131403	T	Toxicity in Zucker rat sub-chronic fa/fa prediabetic model assessed as increase in food consumption at 10 mg/kg, po qd during 10 days study	Rattus norvegicus	2	ALA4130359	organism-based format	Scientific Literature
9.	ALA4131404	T	Toxicity in Zucker rat sub-chronic fa/fa prediabetic model assessed as effect on liver enzymes at 10 mg/kg, po qd during 10 days study	Rattus norvegicus	2	ALA4130359	organism-based format	Scientific Literature
10.	ALA4131405	B	Inhibition of fluormone ES2 green binding to recombinant full length human ERalpha expressed in insect cells by fluorescence polarization assay	Homo sapiens	2	ALA4130359	cell-based format	Scientific Literature
11.	ALA4131406	B	Inhibition of fluormone ES2 binding to recombinant full length human ERbeta expressed in insect cells by fluorescence polarization assay	Homo sapiens	2	ALA4130359	cell-based format	Scientific Literature
12.	ALA4131407	B	Inhibition of fluormone PPARgamma Green binding to recombinant N-terminal GST-tagged human PPARgamma LBD by fluorescence polarization assay	Homo sapiens	2	ALA4130359	single protein format	Scientific Literature
13.	ALA4131408	B	Agonist activity at recombinant GST-tagged human PPARalpha LBD assessed as fluorescein-labeled coactivator peptide recruitment preincubated with enzyme followed by coactivator addition by LanthaScreen TR-FRET assay	Homo sapiens	1	ALA4130359	single protein format	Scientific Literature
14.	ALA4131409	B	Agonist activity at recombinant GST-tagged human PPARdelta LBD assessed as fluorescein-labeled coactivator peptide recruitment preincubated with enzyme followed by coactivator addition by LanthaScreen TR-FRET assay	Homo sapiens	1	ALA4130359	single protein format	Scientific Literature
15.	ALA4131410	B	Agonist activity at recombinant GST-tagged human LXRalpha LBD assessed as fluorescein-labeled coactivator peptide recruitment preincubated with enzyme followed by coactivator addition by LanthaScreen TR-FRET assay	Homo sapiens	1	ALA4130359	single protein format	Scientific Literature
16.	ALA4131411	B	Agonist activity at recombinant GST-tagged human LXRbeta LBD assessed as fluorescein-labeled coactivator peptide recruitment preincubated with enzyme followed by coactivator addition by LanthaScreen TR-FRET assay	Homo sapiens	1	ALA4130359	single protein format	Scientific Literature
17.	ALA4131412	B	Agonist activity at recombinant GST-tagged human RXRalpha LBD assessed as fluorescein-labeled coactivator peptide recruitment preincubated with enzyme followed by coactivator addition by LanthaScreen TR-FRET assay	Homo sapiens	1	ALA4130359	single protein format	Scientific Literature
18.	ALA4131413	B	Agonist activity at recombinant GST-tagged human RARbeta LBD assessed as fluorescein-labeled coactivator peptide recruitment preincubated with enzyme followed by coactivator addition by LanthaScreen TR-FRET assay	Homo sapiens	1	ALA4130359	single protein format	Scientific Literature
19.	ALA4131414	B	Antagonist activity at recombinant GST-tagged human PPARalpha LBD assessed as inhibition of GW7647-induced fluorescein-labeled coactivator peptide recruitment preincubated with enzyme followed by coactivator addition by LanthaScreen TR-FRET assay	Homo sapiens	1	ALA4130359	single protein format	Scientific Literature
20.	ALA4131415	B	Antagonist activity at recombinant GST-tagged human PPARdelta LBD assessed as inhibition of GW0742-induced fluorescein-labeled coactivator peptide recruitment preincubated with enzyme followed by coactivator addition by LanthaScreen TR-FRET assay	Homo sapiens	1	ALA4130359	single protein format	Scientific Literature